• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    BioOptics Stock Watch
    Markets
    Stocks
    ETFs
    Tools
    Markets:
    Overview
    News
    Currencies
    International
    Treasuries

    Avantor, Inc. Common Stock (NY:AVTR)

    11.82 +0.77 (+6.97%)
    Official Closing Price Updated: 7:00 PM EDT, Oct 31, 2025 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Headline News about Avantor, Inc. Common Stock

    < Previous 1 2 3 4 5 6 7 8 9 Next >
    Avantor (AVTR) Stock Trades Up, Here Is Why
    Shares of life sciences company Avantor (NYSE:AVTR) jumped 4.8% in the afternoon session after a director purchased a significant amount of company stock, signaling strong insider confidence. 
    Via StockStory
    1 Healthcare Stock with Impressive Fundamentals and 2 We Ignore
    Healthcare companies are pushing the status quo by innovating in areas like drug development and digital health. Despite the rosy long-term prospects, short-term headwinds such as COVID inventory... 
    Via StockStory
    Topics Stocks
    AVTR Q3 Deep Dive: Strategic Overhaul Launched Amid Margin and Execution Challenges
    Life sciences company Avantor (NYSE:AVTR) fell short of the markets revenue expectations in Q3 CY2025, with sales falling 5.3% year on year to $1.62 billion. Its non-GAAP profit of $0.22 per share was... 
    Via StockStory
    Topics Economy
    Stocks Slide As Powell Cools Rate-Cut Hopes: These 15 Stocks Are Feeling The Pinch
    Stocks fell as Fed Chair Powell warned a December rate cut is uncertain, citing data gaps and policy division. 
    Via Benzinga
    Topics Economy
    Earnings Scheduled For October 29, 2025
     
    Via Benzinga
    Avantor's Earnings Outlook
     
    Via Benzinga
    Avantor Plummets 17.4% as Disappointing Q3 Results and Impairment Charge Rock Investor Confidence
    Avantor (NYSE: AVTR), a leading global provider of mission-critical products and services to customers in the biopharma, healthcare, education & government, and advanced technologies & applied... 
    Via MarketMinute
    Topics Artificial Intelligence Economy Supply Chain
    Why Avantor (AVTR) Shares Are Trading Lower Today
    Shares of life sciences company Avantor (NYSE:AVTR) fell 17.4% in the afternoon session after the company reported disappointing third-quarter 2025 results that missed revenue expectations and included... 
    Via StockStory
    Topics Artificial Intelligence
    12 Health Care Stocks Moving In Wednesday's Intraday Session
     
    Via Benzinga
    What Analysts Are Saying About Avantor Stock
     
    Via Benzinga
    Avantor Struggles With Soft Demand But Backs Long-Term Value Through Buyback
    Avantor stock fell after Q3 earnings and revenue missed estimates, leading the company to cut 2025 guidance but approve a $500 million buyback. 
    Via Benzinga
    Avantor Inc (NYSE:AVTR) Stock Plummets 17% After Q3 Revenue Miss
    Avantor's Q3 2025 results missed revenue expectations, causing a sharp stock drop. While earnings per share met targets, sales fell 5.3% year-over-year. 
    Via Chartmill
    12 Health Care Stocks Moving In Wednesday's Pre-Market Session
     
    Via Benzinga
    Avantor (NYSE:AVTR) Misses Q3 Sales Expectations, Stock Drops 17.9%
    Life sciences company Avantor (NYSE:AVTR) fell short of the markets revenue expectations in Q3 CY2025, with sales falling 5.3% year on year to $1.62 billion. Its non-GAAP profit of $0.22 per share was... 
    Via StockStory
    Earnings To Watch: Avantor (AVTR) Reports Q3 Results Tomorrow
    Life sciences company Avantor (NYSE:AVTR) will be announcing earnings results this Wednesday before market open. Here’s what investors should know. 
    Via StockStory
    Topics Artificial Intelligence
    Avantor (AVTR) Stock Trades Up, Here Is Why
    Shares of life sciences company Avantor (NYSE:AVTR) jumped 2.9% in the afternoon session after Bank of America Securities maintained its "Buy" rating on the company. This followed a similar move from... 
    Via StockStory
    Topics Artificial Intelligence
    Avantor (AVTR): Buy, Sell, or Hold Post Q2 Earnings?
    Since April 2025, Avantor has been in a holding pattern, posting a small return of 2.3% while floating around $15.30. The stock also fell short of the S&P 500’s 30.6% gain during that period. 
    Via StockStory
    Topics Stocks
    Avantor (AVTR) Stock Is Up, What You Need To Know
    Shares of life sciences company Avantor (NYSE:AVTR) jumped 4.9% in the afternoon session after sentiment towards the stock improved following a series of positive developments, including an analyst... 
    Via StockStory
    Topics Government
    Research Tools & Consumables Stocks Q2 Recap: Benchmarking Avantor (NYSE:AVTR)
    Earnings results often indicate what direction a company will take in the months ahead. With Q2 behind us, let’s have a look at Avantor (NYSE:AVTR) and its peers. 
    Via StockStory
    Topics Economy
    Deep Dive Into Avantor Stock: Analyst Perspectives (11 Ratings)
     
    Via Benzinga
    Healthcare Sector Navigates Turbulent Waters as Drug Pricing Agreements Reshape Market Landscape
    September 30, 2025 – The healthcare sector today finds itself at a pivotal juncture, experiencing a complex mix of optimism and apprehension. While a landmark drug-pricing agreement between... 
    Via MarketMinute
    Topics Artificial Intelligence Economy Government
    Agilent (A) Soars as White House-Pfizer Drug-Pricing Agreement Signals New Era for Pharma
    Washington D.C. – September 30, 2025 – Shares of Agilent Technologies (NYSE: A) experienced a significant upward movement today, closing strong amidst breaking news of a landmark drug-pricing agreement... 
    Via MarketMinute
    Topics Artificial Intelligence Economy Government
    Pharmaceutical Pricing Shake-Up Casts Long Shadow on Biotech Suppliers, Bruker Navigates Headwinds Amidst Market Volatility
    As of September 30, 2025, the financial markets are grappling with the implications of a landmark drug-pricing agreement between the White House and pharmaceutical giant Pfizer (NYSE: PFE), a move... 
    Via MarketMinute
    Topics Economy Government Supply Chain
    Bruker, Agilent, Revvity, Avantor, and Bio-Techne Shares Are Soaring, What You Need To Know
    A number of stocks jumped in the afternoon session after reports revealed a potential drug-pricing agreement between the White House and the pharmaceutical industry. 
    Via StockStory
    Topics Government
    3 Cash-Producing Stocks We Keep Off Our Radar
    A company that generates cash isn’t automatically a winner. Some businesses stockpile cash but fail to reinvest wisely, limiting their ability to expand. 
    Via StockStory
    Why Avantor (AVTR) Stock Is Trading Lower Today
    Shares of life sciences company Avantor (NYSE:AVTR) fell 2.7% in the afternoon session after RBC Capital Markets lowered its price target on the stock to $16 from $17. 
    Via StockStory
    Topics Artificial Intelligence Economy
    3 Healthcare Stocks with Warning Signs
    From novel pharmaceuticals to telemedicine, most healthcare companies are on a mission to drive better patient outcomes. But financial performance has lagged recently as players offloaded surplus COVID... 
    Via StockStory
    Topics Stocks
    SoFi, Warner Bros. Discovery, Avantor, Conagra, Nvidia: What Sparked Heavy After-Hours Trading In These 5 Stocks?
    SoFi’s record run triggered increased activity in the stock, while underperformance proved positive for certain other names. 
    Via Stocktwits
    Topics Economy
    1 Value Stock to Target This Week and 2 Facing Challenges
    Value stocks typically trade at discounts to the broader market, offering patient investors the opportunity to buy businesses when they’re out of favor. The key risk, however, is that these stocks are... 
    Via StockStory
    Topics Retirement
    Repligen, Revvity, Avantor, Fortrea, and Azenta Shares Skyrocket, What You Need To Know
    A number of stocks jumped in the afternoon session after the major indices rebounded, as Fed Chair Jerome Powell delivered dovish remarks at the much-awaited Jackson Hole symposium. Powell suggested... 
    Via StockStory
    Topics Economy
    < Previous 1 2 3 4 5 6 7 8 9 Next >
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the Privacy Policy and Terms Of Service.
    © 2025 FinancialContent. All rights reserved.